Prevention of metabolic syndrome in pregnant women based on study of body composition

Показати скорочений опис матеріалу

dc.contributor.author Dovgan, N. A. en
dc.contributor.author Plakida, A. L. en
dc.date.accessioned 2022-01-14T09:50:15Z
dc.date.available 2022-01-14T09:50:15Z
dc.date.issued 2021
dc.identifier.citation Dovgan N. A. Prevention of metabolic syndrome in pregnant women based on study of body composition / N. A. Dovgan, A. L. Plakida // Basic medical science for endocrinology 2021: наук.-практ. конф., 18–19 листопада 2021 року, Івано-Франківськ: матер. – Івано-Франківськ, 2021. – С. 27–29. uk_UA
dc.identifier.uri https://repo.odmu.edu.ua:443/xmlui/handle/123456789/10735
dc.description.abstract Metabolic syndrome (MS) is a higly significant public health problem. Its prevalence throughout the world is growing steadily every year, and in some countries, it reaches a third of the adult population. Obesity is a major component of MS and a significant independent risk factor for developing many gestational complications. The study included 46 women aged 22 to 41 years. Studies began at 2–4 weeks of gestation and continued until delivery. The bioimpedance method using a body composition monitor “Omron BF-512”, Japan, was used to study the body’s composition to determine of muscle and fat components, and the level of visceral fat. Biochemical studies included the determination of blood glucose, glucose tolerance, insulin, triglycerides, high and low-density lipoproteins by standard methods. A close relationship was found between the initial value of the fat component and the amount of weight gain during pregnancy. Of prime importance is the amount of weight gain during pregnancy. en
dc.language.iso en en
dc.subject metabolic syndrome en
dc.subject pregnancy en
dc.subject obesity en
dc.title Prevention of metabolic syndrome in pregnant women based on study of body composition en
dc.type Article en


Долучені файли

Даний матеріал зустрічається у наступних зібраннях

Показати скорочений опис матеріалу